Opponents to the new comparative effectiveness research (CER) legislation in the US are warning about a one-size-fits-all treatment approach and rationing of health care. In this interview, IHI's Don Berwick talks about the value of CER in helping doctors avoid ineffective or more costly approaches that might not work, and whether CER will help control health care costs in the US.